dobutamine has been researched along with Muscular Dystrophy, Duchenne in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meyers, TA; Townsend, D | 1 |
Fischer, G; Stephani, U; van Baalen, A; von Spiczak, S | 1 |
Bauer, R; Blain, A; Bushby, K; Greally, E; Laval, S; Lochmüller, H; MacGowan, GA; Straub, V | 1 |
Beltramo, F; Bosser, G; Burger, G; Lethor, JP; Lucron, H; Marçon, F; Marie, PY | 1 |
Day, SM; Favre, EG; Metzger, JM; Michele, DE; Townsend, D; Yasuda, S | 1 |
Barber, BJ; Benson, DW; Cripe, LH; Markham, LW; Spicer, RL; Weidner, N; Wong, BL | 1 |
Allen, JM; Blankinship, MJ; Chamberlain, JS; Gregorevic, P; Metzger, JM; Townsend, D | 1 |
7 other study(ies) available for dobutamine and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dystrophin; Fibrosis; Heart Ventricles; Hemodynamics; Mice; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardial Contraction; Ventricular Function, Right | 2015 |
Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Male; Muscular Dystrophy, Duchenne; Time Factors | 2008 |
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dobutamine; Heart Failure; Hemodynamics; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Inbred Strains; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Papillary Muscles | 2010 |
Evidence of early impairments in both right and left ventricular inotropic reserves in children with Duchenne's muscular dystrophy.
Topics: Adolescent; Child; Dobutamine; Female; Humans; Male; Muscular Dystrophy, Duchenne; Radionuclide Ventriculography; Retrospective Studies; Ventricular Dysfunction, Left | 2004 |
Dystrophic heart failure blocked by membrane sealant poloxamer.
Topics: Animals; Calcium; Cardiomyopathies; Dobutamine; Dystrophin; Hemodynamics; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardial Contraction; Myocytes, Cardiac; Poloxamer | 2005 |
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response Relationship, Drug; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Muscular Dystrophy, Duchenne; Palliative Care; Quality of Life; Time Factors | 2006 |
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.
Topics: Adrenergic beta-Agonists; Animals; Blotting, Western; Cardiomyopathies; Dependovirus; Dobutamine; Dystrophin; Fluorescent Antibody Technique; Genetic Therapy; Genetic Vectors; Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardium | 2007 |